WMSA
LOXO

Weiss Multi-Strategy Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,000
Closed -$231K – 722
2018
Q1 		$231K Sell
2,000
-17,000
-89% -$1.81M 0.01% 498
2017
Q4 		$1.6M Buy
19,000
+4,000
+27% +$333K 0.04% 378
2017
Q3 		$1.38M Buy
15,000
+3,500
+30% +$272K 0.05% 349
2017
Q2 		$922K Buy
+11,500
New +$637K 0.04% 369

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LOXO Position: Q2 2018 in Review

Weiss Multi-Strategy Advisers sold out of Loxo Oncology, Inc (LOXO) in Q2 2018, closing a stake of 2,000 shares — an estimated $231K sold.

Weiss Multi-Strategy Advisers first reported a position in LOXO in Q2 2017 and held it in 4 quarters. The position peaked at $1.6M in Q4 2017. 213 funds tracked by Wall St. Rank hold LOXO as of Q2 2018.

  • Weiss Multi-Strategy Advisers reported no remaining Loxo Oncology, Inc position as of Q2 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 2,000 Loxo Oncology, Inc shares in Q2 2018, an estimated $231K.
  • Weiss Multi-Strategy Advisers first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Loxo Oncology, Inc position peaked at $1.6M in Q4 2017.
  • 213 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.